Cbl Proto-Oncogene B (CBLB) c.197A>T Mutation Induces Mild Metabolic Dysfunction in Partial Type I Multiple Symmetric Lipomatosis (MSL).
Ke ChenXinxing WanLiling ZhaoShaoli ZhaoLin PengWenjun YangJingjing YuanLiyong ZhuZhao-Hui MoPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2020)
This study analyzed clinical, histopathological, and cellular and molecular biological characterizations of 13 Type I MSL patients and identified the CBLB c.197A>T heterozygous mutation that could be responsible for MSL metabolic dysfunction or even MSL development.